AIMS/HYPOTHESIS: Intake of n-3 polyunsaturated fatty acids reduces adipose tissue mass, preferentially in the abdomen. The more pronounced effect of marine-derived eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids on adiposity, compared with their precursor alpha-linolenic acid, may be mediated by changes in gene expression and metabolism in white fat. METHODS: The effects of EPA/DHA concentrate (6% EPA, 51% DHA) admixed to form two types of high-fat diet were studied in C57BL/6J mice. Oligonucleotide microarrays, cDNA PCR subtraction and quantitative real-time RT-PCR were used to characterise gene expression. Mitochondrial proteins were quantified using immunoblots. Fatty acid oxidation and synthesis were measured in adipose tissue fragments. RESULTS: Expression screens revealed upregulation of genes for mitochondrial proteins, predominantly in epididymal fat when EPA/DHA concentrate was admixed to a semisynthetic high-fat diet rich in alpha-linolenic acid. This was associated with a three-fold stimulation of the expression of genes encoding regulatory factors for mitochondrial biogenesis and oxidative metabolism (peroxisome proliferator-activated receptor gamma coactivator 1 alpha [Ppargc1a, also known as Pgc1alpha] and nuclear respiratory factor-1 [Nrf1] respectively). Expression of genes for carnitine palmitoyltransferase 1A and fatty acid oxidation was increased in epididymal but not subcutaneous fat. In the former depot, lipogenesis was depressed. Similar changes in adipose gene expression were detected after replacement of as little as 15% of lipids in the composite high-fat diet with EPA/DHA concentrate, while the development of obesity was reduced. The expression of Ppargc1a and Nrf1 was also stimulated by n-3 polyunsaturated fatty acids in 3T3-L1 cells. CONCLUSIONS/INTERPRETATION: The anti-adipogenic effect of EPA/DHA may involve a metabolic switch in adipocytes that includes enhancement of beta-oxidation and upregulation of mitochondrial biogenesis.

Department of Adipose Tissue Biology Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Biochem J. 1997 Oct 1;327 ( Pt 1):225-31 PubMed

Mol Cell Biol. 2000 Mar;20(5):1868-76 PubMed

Diabetes. 2002 Apr;51(4):1281-6 PubMed

Endocrinology. 2003 Dec;144(12):5166-71 PubMed

Cell. 2003 Apr 18;113(2):159-70 PubMed

Lipids. 2002 Dec;37(12):1113-23 PubMed

Am J Physiol Cell Physiol. 2000 Sep;279(3):C670-81 PubMed

Nat Biotechnol. 2000 Mar;18(3):345-8 PubMed

FASEB J. 2000 Sep;14 (12 ):1793-800 PubMed

J Biol Chem. 2003 Aug 29;278(35):33370-6 PubMed

Int J Obes Relat Metab Disord. 1997 Nov;21(11):955-62 PubMed

J Clin Invest. 2004 Nov;114(9):1281-9 PubMed

Int J Obes Relat Metab Disord. 2004 Jan;28(1):176-9 PubMed

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2058-63 PubMed

Br J Nutr. 2000 Aug;84(2):175-84 PubMed

Proc Nutr Soc. 1999 Aug;58(3):633-46 PubMed

Biochem Biophys Res Commun. 1999 May 27;259(1):85-90 PubMed

Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun;60(5-6):351-6 PubMed

J Lipid Res. 2002 Nov;43(11):1809-17 PubMed

Cell. 1998 Mar 20;92(6):829-39 PubMed

Metabolism. 1996 Dec;45(12):1539-46 PubMed

Diabetes. 2004 May;53(5):1385-93 PubMed

J Hum Nutr Diet. 2004 Oct;17 (5):449-59 PubMed

Int J Obes Relat Metab Disord. 1997 Aug;21(8):637-43 PubMed

Int J Obes Relat Metab Disord. 1993 Apr;17(4):223-36 PubMed

Proc Natl Acad Sci U S A. 1983 Oct;80(20):6167-71 PubMed

Endocr Rev. 2003 Feb;24(1):78-90 PubMed

Nature. 2000 Apr 6;404(6778):635-43 PubMed

J Anim Sci. 2004 Mar;82(3):916-24 PubMed

J Lipid Res. 1997 Oct;38(10):1963-72 PubMed

Br J Nutr. 2002 Jul;88(1):11-8 PubMed

Am J Physiol. 1996 May;270(5 Pt 1):E768-75 PubMed

Biochim Biophys Acta. 2003 Jan 31;1609(2):127-43 PubMed

Genes Dev. 2004 Feb 15;18(4):357-68 PubMed

J Biol Chem. 1999 Jun 18;274(25):17541-4 PubMed

Biochem J. 1999 Sep 15;342 Pt 3:537-44 PubMed

Physiol Genomics. 2003 Dec 16;16(1):99-106 PubMed

Eur J Biochem. 2002 Jan;269(1):19-28 PubMed

Obes Res. 2003 Oct;11(10 ):1182-91 PubMed

Int J Obes Relat Metab Disord. 1997 Jun;21(6):439-44 PubMed

Trends Cardiovasc Med. 2004 Feb;14(2):77-81 PubMed

Lipids. 2004 Dec;39(12):1177-85 PubMed

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7 PubMed

Biochem J. 1970 May;117(5):861-77 PubMed

Biochim Biophys Acta. 2004 Aug 12;1679(2):164-73 PubMed

Diabetes. 2001 Aug;50(8):1883-90 PubMed

Cell. 2004 Oct 1;119(1):121-35 PubMed

FEBS Lett. 2004 Jul 2;569(1-3):245-8 PubMed

Curr Opin Clin Nutr Metab Care. 2004 Mar;7(2):151-6 PubMed

Omega-3 PUFAs prevent bone impairment and bone marrow adiposity in mouse model of obesity

Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue

The Anti-Obesogenic Effect of Lean Fish Species is Influenced by the Fatty Acid Composition in Fish Fillets

Omega-3 Phospholipids from Krill Oil Enhance Intestinal Fatty Acid Oxidation More Effectively than Omega-3 Triacylglycerols in High-Fat Diet-Fed Obese Mice

Reduced Number of Adipose Lineage and Endothelial Cells in Epididymal fat in Response to Omega-3 PUFA in Mice Fed High-Fat Diet

Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity

Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids

Influence of extractive solvents on lipid and fatty acids content of edible freshwater algal and seaweed products, the green Microalga Chlorella kessleri and the Cyanobacterium Spirulina platensis

Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice

Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice

Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet

Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids

The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice

AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids

n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet

Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet